LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Начало・Списък с акции・Globus Medical Inc (Class A)

Globus Medical Inc (Class A)

Отворен

Сектор Здравеопазване

74.67 -0.4

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

74.21

Максимум

75.71

Ключови измерители
By Trading Economics
Приходи	39M 32M
Продажби	23M 630M
P/E Средно за сектора	126.83 104.138
EPS	0.75
Марж на печалбата	5.044
Служители	5,000
EBITDA	43M 128M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+6.28 upside

Дивиденти
By Dow Jones
Следващи печалби	5.11.2024 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	56M 10B
Предишно отваряне	75.07
Предишно затваряне	74.67

Настроения в новините

By Acuity

20%

80%

45 / 390 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

73.49 / 75.07 Подкрепа & съпротива

Globus Medical Inc (Class A) Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.11.2024 г., 23:05 ч. UTC

Топ новини

Fitch Affirms Australia's Sovereign AAA Rating, But Warns Of Mounting Budget Risks

3.11.2024 г., 21:12 ч. UTC

Печалби

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects -- Update

3.11.2024 г., 20:59 ч. UTC

Печалби

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects

3.11.2024 г., 23:34 ч. UTC

Топ новини

Stocks Poised for Lower Open -- Barrons.com

3.11.2024 г., 23:16 ч. UTC

Топ новини

Печалби

Berkshire Hathway Earnings Weren't as Bad as They Looked -- Barrons.com

3.11.2024 г., 22:50 ч. UTC

Придобивния, сливания и поглъщания

Santos Says Working Interest in PNG LNG Now 39.9%

3.11.2024 г., 22:50 ч. UTC

Придобивния, сливания и поглъщания

Santos Says Kumul to Assume $90 Million of Project Finance Debt Associated With Stake

3.11.2024 г., 22:49 ч. UTC

Придобивния, сливания и поглъщания

Santos Says Final Payment Takes Total Cash Consideration to $602 Million

3.11.2024 г., 22:49 ч. UTC

Придобивния, сливания и поглъщания

Santos Receives Final $241 Million Payment From Kumul

3.11.2024 г., 22:48 ч. UTC

Придобивния, сливания и поглъщания

Santos Completes Sale of 2.6% Interest in PNG LNG to Kumul Petroleum

3.11.2024 г., 20:37 ч. UTC

Печалби

Westpac FY 2024 Deposits Increased 5% to A$674 Billion

3.11.2024 г., 20:37 ч. UTC

Печалби

Westpac FY 2024 Loans Increased 4% to A$807 Billion

3.11.2024 г., 20:37 ч. UTC

Печалби

Westpac FY 2024 Impairment Charges 7 Bps of Loans

3.11.2024 г., 20:37 ч. UTC

Печалби

Westpac FY 2024 Operating Expenses A$10.94 Billion, Up 7% Excluding Notable Items

3.11.2024 г., 20:36 ч. UTC

Печалби

Westpac FY 2024 Non-Interest Income A$2.84 Billion, Down 15%

3.11.2024 г., 20:35 ч. UTC

Печалби

Westpac FY 2024 CET1 Level 2 Capital Ratio 12.5%, Up 11 Bps

3.11.2024 г., 20:35 ч. UTC

Печалби

Westpac Raises Share Buyback Program by A$1 Billion

3.11.2024 г., 20:35 ч. UTC

Печалби

Westpac Final Dividend A$0.76/Share

3.11.2024 г., 20:33 ч. UTC

Печалби

Westpac FY 2024 Net Interest Margin Down 1 Bps at 1.95%

3.11.2024 г., 20:32 ч. UTC

Печалби

Westpac FY 2024 Revenue A$21.59 Billion, Flat on FY 2023

3.11.2024 г., 20:32 ч. UTC

Печалби

Westpac FY Net Profit A$6.99 Billion, Down 3%

3.11.2024 г., 18:09 ч. UTC

Топ новини

Boeing Had a Big Week. This One Is Even Bigger. -- Barrons.com

3.11.2024 г., 10:30 ч. UTC

Топ новини

Fed Prepares Rate Cut Amid Economic Contradictions -- WSJ

3.11.2024 г., 03:00 ч. UTC

Топ новини

Disgraced Lebanese Central Banker Who Was a Fugitive Now Awaits His Fate -- WSJ

2.11.2024 г., 13:53 ч. UTC

Топ новини

Печалби

Придобивния, сливания и поглъщания

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2.11.2024 г., 13:44 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2.11.2024 г., 13:00 ч. UTC

Топ новини

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2.11.2024 г., 12:58 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2.11.2024 г., 12:48 ч. UTC

Топ новини

Печалби

Придобивния, сливания и поглъщания

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2.11.2024 г., 12:32 ч. UTC

Печалби

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Globus Medical Inc (Class A) Прогноза

Ценова цел

By TipRanks

6.28% нагоре

12-месечна прогноза

Среден 79.58 USD 6.28%

Висок 100 USD

Нисък 55 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за Globus Medical Inc (Class A) през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

15 ratings

Купи

Задържане

Продай

Според 15 анализатори, дали борсови рейтинги на Globus Medical Inc (Class A) през последните 3 месеца.

Техническа оценка

By Trading Central

73.49 / 75.07Подкрепа & съпротива

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

Настроение

By Acuity

45 / 390 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

Относно Globus Medical Inc (Class A)

Globus Medical, Inc. is a medical device company. The Company is primarily focused on implants that promote healing in patients with musculoskeletal disorders. The Company group its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are computer-assisted intelligent systems designed to improve a surgeon’s capabilities, and ultimately improve patient care and reduce radiation exposure for all involved. Its INR solutions include the ExcelsiusGPS platform, which is a robotic guidance and navigation system that supports minimally invasive and open procedures with screw and interbody spacer placement applications.